Artivion (AORT) Total Current Liabilities (2010 - 2026)
Artivion's (AORT) quarterly Total Current Liabilities came in at $92.7 million in Q1 2026, up 78.48% YoY from $51.9 million in Q1 2025, and down 8.72% on a QoQ basis from $101.6 million in Q4 2025.
Artivion (AORT) Total Current Liabilities (2010 - 2026) Analysis & Trends
Artivion (AORT) has 17 years of Total Current Liabilities data on file, last reported at $92.7 million in Q1 2026.
- Quarterly Total Current Liabilities rose 78.48% year-over-year to $92.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $92.7 million (up 78.48% YoY) and the FY2025 annual result came in at $101.6 million, up 51.98% from the prior year.
- Total Current Liabilities retreated to $92.7 million in Q1 2026, from $101.6 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $152.8 million in Q3 2024 to a low of $41.6 million in Q2 2022.
- A 5-year average of $65.2 million and a median of $55.0 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Current Liabilities surged 178.09% — and 2025, when it plunged 43.84%.
- Tracing AORT's Total Current Liabilities over 5 years: stood at $49.7 million in 2022, then rose by 16.48% to $57.9 million in 2023, then rose by 15.49% to $66.8 million in 2024, then soared by 51.98% to $101.6 million in 2025, then decreased by 8.72% to $92.7 million in 2026.
- The last three Total Current Liabilities figures came in at $92.7 million (Q1 2026), $101.6 million (Q4 2025), and $85.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Artivion | 1.38 Bn | 1.30 Bn | 80.52 Mn | 106.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 106.93 Mn |
| Mar 31, 2026 | 92.70 Mn |
| Dec 31, 2025 | 101.56 Mn |
| Sep 30, 2025 | 85.84 Mn |
| Jun 30, 2025 | 66.67 Mn |
| Mar 31, 2025 | 51.94 Mn |
| Dec 31, 2024 | 66.82 Mn |
| Sep 30, 2024 | 152.84 Mn |
| Jun 30, 2024 | 50.58 Mn |
| Mar 31, 2024 | 45.83 Mn |
| Dec 31, 2023 | 57.86 Mn |
| Sep 30, 2023 | 54.96 Mn |
| Jun 30, 2023 | 56.23 Mn |
| Mar 31, 2023 | 43.96 Mn |
| Dec 31, 2022 | 49.68 Mn |
| Sep 30, 2022 | 45.99 Mn |
| Jun 30, 2022 | 41.65 Mn |
| Mar 31, 2022 | 42.84 Mn |
| Dec 31, 2021 | 44.95 Mn |
| Sep 30, 2021 | 61.13 Mn |